Table of Contents
Understanding QT prolongation is crucial for healthcare professionals and students alike. It involves changes in the electrical activity of the heart that can lead to serious arrhythmias. Certain drugs are known to affect cardiac repolarization, potentially causing QT prolongation.
What Is QT Prolongation?
QT prolongation refers to an extension of the QT interval on an electrocardiogram (ECG). This interval represents the time it takes for the heart’s ventricles to depolarize and then repolarize. When prolonged, it can predispose individuals to dangerous arrhythmias such as torsades de pointes.
Drugs That Can Cause QT Prolongation
- Antiarrhythmic drugs: Amiodarone, sotalol, dofetilide
- Antibiotics: Macrolides (erythromycin, clarithromycin), fluoroquinolones (ciprofloxacin, levofloxacin)
- Antipsychotics: Haloperidol, ziprasidone, quetiapine
- Antidepressants: Tricyclic antidepressants (amitriptyline), SSRIs (citalopram, escitalopram)
- Other medications: Ondansetron, methadone, domperidone
Mechanisms of Drug-Induced QT Prolongation
Many drugs prolong the QT interval by blocking the human Ether-à-go-go-Related Gene (hERG) potassium channels. This blockade delays repolarization, extending the duration of the QT interval. Genetic predispositions can also increase susceptibility to drug-induced QT prolongation.
Risk Factors and Monitoring
- Electrolyte imbalances (hypokalemia, hypomagnesemia)
- Pre-existing heart conditions
- Concomitant use of multiple QT-prolonging drugs
- Genetic predispositions
- Female gender
Monitoring includes baseline and periodic ECGs, electrolyte assessments, and reviewing medication regimens. Adjustments or discontinuation of offending drugs may be necessary to prevent adverse events.
Conclusion
Understanding the drugs that affect cardiac repolarization and their mechanisms is essential for safe prescribing practices. Awareness of risk factors and vigilant monitoring can mitigate the dangers associated with QT prolongation.